PT - JOURNAL ARTICLE AU - François Brial AU - Julien Chilloux AU - Trine Nielsen AU - Sara Vieira-Silva AU - Gwen Falony AU - Petros Andrikopoulos AU - Michael Olanipekun AU - Lesley Hoyles AU - Fatima Djouadi AU - Ana L Neves AU - Andrea Rodriguez-Martinez AU - Ghiwa Ishac Mouawad AU - Nicolas Pons AU - Sofia Forslund AU - Emmanuelle Le-chatelier AU - Aurélie Le Lay AU - Jeremy Nicholson AU - Torben Hansen AU - Tuulia Hyötyläinen AU - Karine Clément AU - Matej Oresic AU - Peer Bork AU - Stanislav Dusko Ehrlich AU - Jeroen Raes AU - Oluf Borbye Pedersen AU - Dominique Gauguier AU - Marc-Emmanuel Dumas TI - Human and preclinical studies of the host–gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health AID - 10.1136/gutjnl-2020-323314 DP - 2021 May 05 TA - Gut PG - gutjnl-2020-323314 4099 - http://gut.bmj.com/content/early/2021/05/11/gutjnl-2020-323314.short 4100 - http://gut.bmj.com/content/early/2021/05/11/gutjnl-2020-323314.full AB - Objective Gut microbial products are involved in regulation of host metabolism. In human and experimental studies, we explored the potential role of hippurate, a hepatic phase 2 conjugation product of microbial benzoate, as a marker and mediator of metabolic health.Design In 271 middle-aged non-diabetic Danish individuals, who were stratified on habitual dietary intake, we applied 1H-nuclear magnetic resonance (NMR) spectroscopy of urine samples and shotgun-sequencing-based metagenomics of the gut microbiome to explore links between the urine level of hippurate, measures of the gut microbiome, dietary fat and markers of metabolic health. In mechanistic experiments with chronic subcutaneous infusion of hippurate to high-fat-diet-fed obese mice, we tested for causality between hippurate and metabolic phenotypes.Results In the human study, we showed that urine hippurate positively associates with microbial gene richness and functional modules for microbial benzoate biosynthetic pathways, one of which is less prevalent in the Bacteroides 2 enterotype compared with Ruminococcaceae or Prevotella enterotypes. Through dietary stratification, we identify a subset of study participants consuming a diet rich in saturated fat in which urine hippurate concentration, independently of gene richness, accounts for links with metabolic health. In the high-fat-fed mice experiments, we demonstrate causality through chronic infusion of hippurate (20 nmol/day) resulting in improved glucose tolerance and enhanced insulin secretion.Conclusion Our human and experimental studies show that a high urine hippurate concentration is a general marker of metabolic health, and in the context of obesity induced by high-fat diets, hippurate contributes to metabolic improvements, highlighting its potential as a mediator of metabolic health.Data are available upon reasonable request to the corresponding authors